- Latest available (Revised)
- Original (As made)
The Health Service Branded Medicines (Control of Prices and Supply of Information) (No. 2) Regulations 2008
You are here:
- UK Statutory Instruments
- 2008 No. 3258
- Explanatory Note
What Version
More Resources
Status:
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
EXPLANATORY NOTE
(This note is not part of the Regulations)
These Regulations, which apply to the United Kingdom, control the price of presentations of medicines which are supplied for health service purposes. They also require the supply of information relating to those presentations to the Secretary of State.
Regulation 1 includes a definition of presentation.
Regulation 2 specifies the maximum price which may be charged for a presentation which is supplied in England for health service purposes on 1st December 2008, except where regulation 3 or 4 applies. That maximum price is calculated by deducting 3.9 % from the price for which that presentation was on sale for health service purposes in England on 1st December 2008.
Regulation 3 makes provision for presentations which are first supplied for health service purposes in England on or after 1st December 2008 (new presentations).
Regulation 4 exempts the maximum price of low cost presentations from the reduction made by regulation 2.
Regulation 5 enables the Secretary of State to exempt presentations where a maximum price may jeopardise supplies of those presentations for the purposes of the health service.
Regulation 6 makes provision for increases in the price of presentations.
Regulation 7 and the Schedule make provision for enforcement of the controls on the prices of presentations of medicines by imposing specified penalties.
Regulation 8 further amends the Health Service Medicines (Information Relating to Sales of Branded Medicines etc.) Regulations 2007, which require the provision of information to the Secretary of State.
Regulation 9 makes provision for appeals from decisions made under these Regulations by the Secretary of State.
Regulation 10 revokes the Health Service Branded Medicines (Control of Prices and Supply of Information) Regulations 2008.
An Impact Assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available from the Department of Health, Zone 456D, Skipton House, 80 London Road, London SE1 6LH.
Options/Help
Print Options
PrintThe Whole Instrument
PrintThis Explanatory Note only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.